Navigation Links
Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease
Date:3/19/2012

ant cardiovascular effect in some patients, as measured by increases in pulse rate, systolic or diastolic blood pressure, or symptoms, and should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension.

Arcapta Neohaler should be used with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, and in patients who are unusually responsive to sympathomimetic amines.

The most commonly reported adverse reactions in patients taking Arcapta Neohaler (>2% and higher than placebo) were cough (6.5%), nasopharyngitis (5.3%), headache (5.1%), nausea (2.4%), and oropharyngeal pain (2.2%).

Arcapta Neohaler should be used with extreme caution in patients treated with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated.

Arcapta Neohaler should be used with caution in patients treated with additional adrenergic drugs, non-potassium-sparing diuretics, and beta-blockers.

Arcapta capsules must not be swallowed as the intended effects on the lungs will not be obtained. Arcapta capsules are only for oral inhalation and should only be used with the Neohaler device. The Neohaler device should not be used with any other capsules.

Please see full Prescribing Information, including BOXED WARNING at http://www.pharma.us.novartis.com/product/pi/pdf/arcapta.pdf or contact Christine Cascio at 862-778-8026 or christine.cascio@novartis.com.

Disclaimer The foregoing release contains forward-looking statements that can be identified by terminology such as "launches," "launch," "milestone," "continue," "planned," or similar expressions, or by express or i
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data in NEJM shows Novartis drug Signifor® is first therapy to provide rapid, durable benefit for Cushings disease patients in Phase III study
2. FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
3. Unity Management Group Subsidiary Announces First Contracts of 2012 with Purdue Pharma L.P. and Novartis
4. Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility
5. Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
6. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
7. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
8. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
9. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
10. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
11. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ –  ... PHG AEX: PHIA) today announced ... Society of Cardiology (ESC) Congress 2014 ... range of its cardiology solutions serving clinicians and ... prevention and diagnosis, to treatment, ...
(Date:8/28/2014)... Reportlinker.com announces that a new market ... Germany Aesthetic Lasers and Energy Devices Market ... Germany Aesthetic Lasers and Energy ... GlobalData,s new report, "Germany Aesthetic Lasers and Energy ... data on the Germany Aesthetic Lasers and Energy ...
(Date:8/28/2014)... N.J. , Aug. 28, 2014 /PRNewswire-iReach/ -- ... medical device space, is excited to announce they ... the VIEW Plating System and REDUCE Fracture Plating ... anatomic plates used to support multiple indications within ... packaged Lapidus, First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular ...
Breaking Medicine Technology:Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9EDGE Orthopaedics Receives Second FDA Clearance 2
... 8, 2011 PermaDerm™, an engineered skin substitute which ... prepared from a patient,s own skin cells, has been ... that the U.S. Department of Defense awarded more than ... of the therapeutic candidate for the treatment of severe ...
... a Carmel-headquartered software development and solutions firm has been ... 500 and mid-market businesses throughout the world since 1983. ... its extensive supply chain experience to develop supply chain ... Blue Horseshoe Intellectual Property (BHIP). Led ...
Cached Medicine Technology:PermaDerm™ Receives National Media Coverage 2Software Development Firm's New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain 2Software Development Firm's New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain 3
(Date:8/29/2014)... effect, stimulating neurite extension in the presence ... enhancing nerve regeneration following nerve crush injury ... to stimulate nerve regeneration is limited because ... hypertension, and its considerable cost. With long-term ... drugs reportedly cause life-threatening infections. Like FK506, ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... from Cooper City, Fla., understands that there’s a direct ... in the knees, hips and back. "Since conventional shoe ... to design a solution of my own," he said. ... Sole Orthotic provides better support for the foot in ...
(Date:8/29/2014)... News) -- The main strain of a common ... North Africa originated in sub-Saharan Africa, a new ... Staphylococcus aureus (CA-MRSA) infections, which occur ... hospitalized. These infections typically affect the skin and ... touching contaminated objects such as clothing or towels. ...
(Date:8/29/2014)... August 29, 2014 For the fifth ... (Meso Foundation) will be observing September 26th as Mesothelioma ... Plaza, in New York. , Members of the ... RSVP . The Foundation will be providing t-shirts and ... years, mesothelioma community members have received attention from ...
(Date:8/29/2014)... August 29, 2014 PreDiabetes Centers , ... fall season by offering Web shoppers a 20% discount off ... , the Company’s online healthy living shop, beginning September 1. ... top priority when heading into the chilly fall season. , ... During this season, people usually ditch the healthy salads and ...
Breaking Medicine News(10 mins):Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2
... Turkish Farm Minister reported the CNN that first case of ... of bird flu in Europe has been reported from farm ... Following the news of bird flu all farm animals and ... of the disease and possible transmission to humans. Though, wildlife ...
... of cancer patients by doctors in Apollo Hospital. This ... time in India. // Apollo Cancer Hospital is ... a PET-CT guided radiotherapy technology, Director, Vijay Anand Reddy ... Emission Tomography and CT scan is a Computerized Tomography, ...
... calculated the lifetime cost of smoking about 15 cigarettes a day ... . US $150,000 or Rs. 6,000.000 // . This figure is ... ,The study was helped by ‘Clerical Medical’. It found that the ... pounds a week. In a year the smoker blows up ...
... have a crunch and a peppery tinge to lettuce buds ... way into the most divine salad bowls in Indian hotels ... becoming hot favourites for toss-it-up-your-way spreads. Judging by the salad ... wave of flavours for every palate. Infact, lots of Indians ...
... might have spawned an outbreak of disease among otherwise ... Howard Hughes Medical Institute geneticists at Duke University Medical ... restricted to the tropics and subtropics. ,The ... pathogen's expansion may provide a useful model for the ...
... mechanisms that control coordinate gene expression is a ... DNA sequences from multiple vertebrate or invertebrate // ... central to the dynamic interplay between a gene ... phylogenetic footprinting, is based on the hypothesis that ...
Cached Medicine News:Health News:Sex Played A Vital Role For Evolution Of Infectious Diseases 2Health News:Evoprinter, a multigenomic comparative tool for rapid identification of functionally important DNA 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: